FBIO
Fortress Biotech Inc Pref Series A
NASDAQ: FBIOP · HEALTHCARE · BIOTECHNOLOGY
$14.39
-0.21% today
Updated 2026-04-30
Market cap
$76.49M
P/E ratio
—
P/S ratio
1.21x
EPS (TTM)
$-0.86
Dividend yield
—
52W range
$6 – $15
Volume
0.0M
Fortress Biotech Inc Pref Series A (FBIOP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
10.80%
Operating margin
-29.80%
ROE
-108.70%
ROA
-26.60%
Debt/equity
1.22x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-3.80M | — | — | — |
| 2009 | — | $-3.67M | — | — | — |
| 2010 | — | $-9.98M | — | — | — |
| 2011 | — | $-36.36M | — | — | — |
| 2012 | — | $-27.61M | — | — | — |
| 2013 | — | $-37.16M | — | — | — |
| 2014 | — | $-20.39M | — | — | — |
| 2015 | $863000.00 | $-48.43M | 100.00% | -5,855.27% | -5,611.59% |
| 2016 | $16.48M | $-55.09M | 31.13% | -398.73% | -334.31% |
| 2017 | $187.58M | $-66.88M | 14.06% | -47.87% | -35.65% |
| 2018 | $26.88M | $-84.15M | 77.22% | -446.38% | -313.02% |
| 2019 | $36.63M | $-39.96M | 71.25% | -302.54% | -109.09% |
| 2020 | $45.60M | $-46.53M | 67.99% | -206.74% | -102.03% |
| 2021 | $68.79M | $-64.70M | 53.36% | -274.08% | -94.06% |
| 2022 | $75.74M | $-86.58M | 59.37% | -268.76% | -114.30% |
| 2023 | $84.51M | $-60.64M | 72.91% | -168.43% | -71.75% |
| 2024 | $57.67M | $-46.00M | 63.80% | -191.38% | -79.75% |
| 2025 | $63.26M | $6.82M | 66.92% | -111.00% | 10.77% |